About the Product

Description


Ribziff 40 Tablet containing Rabeprazole is used for the management of acidity, gastroesophageal reflux disease (GERD), stomach ulcers, and acid-related disorders. It helps provide relief from excess stomach acid and heartburn symptoms.

Rabeprazole works as a proton pump inhibitor that reduces acid secretion in the stomach, thereby helping protect the gastric lining and improve digestive comfort.

The tablet is widely prescribed in gastroenterology and general medicine practice for long-term acid control therapy, leading to consistent prescription demand.

With increasing prevalence of lifestyle-related digestive disorders and acid reflux conditions, this product offers strong business potential for retailers and distributors. Its established acid-suppressing action, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastroenterology segment.

Common side effects include dizziness, headache, nausea, diarrhea, or constipation. Rarely, it may cause allergic reactions, fatigue, or changes in liver enzymes.

Indicated for gastroesophageal reflux disease (GERD), functional dyspepsia, and related acid reflux conditions.

Use only as prescribed by a healthcare professional. Avoid in cases of known allergies to PPIs or prokinetic agents. Do not discontinue abruptly without consulting your doctor.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ribziff 40 Tablet in the PCD pharma franchise market?

Ribziff 40 Tablet, containing Rabeprazole 40mg, has strong demand in the gastroenterology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on acidity, ulcer, and gastric care portfolios.

Why should medical distributors include Ribziff 40 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for proton pump inhibitor (PPI) therapy used in acid reflux (GERD), gastritis, peptic ulcers, and hyperacidity. Ribziff 40 Tablet helps strengthen a comprehensive gastro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Ribziff 40 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ribziff 40 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Ribziff 40 Tablet distribution?

Wholesalers and medical agencies benefit from strong gastro prescription demand, repeat usage in chronic acid disorders, reliable supply chain support, and good margins when partnering for Ribziff 40 Tablet distribution.

How can I become a distributor or franchise partner for Ribziff 40 Tablet?

Medical distributors, stockists, and wholesalers interested in Ribziff 40 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.